These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 25697482
1. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ. Wang H, Bao W, Jiang F, Che Q, Chen Z, Wang F, Tong H, Dai C, He X, Liao Y, Liu B, Sun J, Wan X. Cancer Lett; 2015 May 01; 360(2):269-79. PubMed ID: 25697482 [Abstract] [Full Text] [Related]
2. Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells. Ali A, Wang Z, Fu J, Ji L, Liu J, Li L, Wang H, Chen J, Caulin C, Myers JN, Zhang P, Xiao J, Zhang B, Li X. Nat Commun; 2013 May 01; 4():2667. PubMed ID: 24157709 [Abstract] [Full Text] [Related]
3. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing. Jiang FZ, He YY, Wang HH, Zhang HL, Zhang J, Yan XF, Wang XJ, Che Q, Ke JQ, Chen Z, Tong H, Zhang YL, Wang FY, Li YR, Wan XP. Oncotarget; 2015 Dec 29; 6(42):44660-74. PubMed ID: 26587974 [Abstract] [Full Text] [Related]
7. REGγ potentiates TGF-β/Smad signal dependent epithelial-mesenchymal transition in thyroid cancer cells. Bhatti MZ, Pan L, Wang T, Shi P, Li L. Cell Signal; 2019 Dec 29; 64():109412. PubMed ID: 31491459 [Abstract] [Full Text] [Related]
8. Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation. Wu AY, Gu LY, Cang W, Cheng MX, Wang WJ, Di W, Huang L, Qiu LH. J Exp Clin Cancer Res; 2019 Apr 25; 38(1):176. PubMed ID: 31023317 [Abstract] [Full Text] [Related]
9. REGγ deficiency promotes premature aging via the casein kinase 1 pathway. Li L, Zhao D, Wei H, Yao L, Dang Y, Amjad A, Xu J, Liu J, Guo L, Li D, Li Z, Zuo D, Zhang Y, Liu J, Huang S, Jia C, Wang L, Wang Y, Xie Y, Luo J, Zhang B, Luo H, Donehower LA, Moses RE, Xiao J, O'Malley BW, Li X. Proc Natl Acad Sci U S A; 2013 Jul 02; 110(27):11005-10. PubMed ID: 23766372 [Abstract] [Full Text] [Related]
10. ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ-proteasome pathway. Cai Q, Zhu H, Dai Y, Zhou Q, Zhang Q, Zhu Q. Mol Carcinog; 2024 Oct 02; 63(10):1874-1891. PubMed ID: 38888205 [Abstract] [Full Text] [Related]
12. Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor. Lai ZY, Tsai KY, Chang SJ, Chuang YJ. Int J Mol Sci; 2021 Aug 16; 22(16):. PubMed ID: 34445495 [Abstract] [Full Text] [Related]
13. REGgamma modulates p53 activity by regulating its cellular localization. Liu J, Yu G, Zhao Y, Zhao D, Wang Y, Wang L, Liu J, Li L, Zeng Y, Dang Y, Wang C, Gao G, Long W, Lonard DM, Qiao S, Tsai MJ, Zhang B, Luo H, Li X. J Cell Sci; 2010 Dec 01; 123(Pt 23):4076-84. PubMed ID: 21084564 [Abstract] [Full Text] [Related]
18. The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression. De Souza C, Madden JA, Minn D, Kumar VE, Montoya DJ, Nambiar R, Zhu Z, Xiao WW, Tahmassebi N, Kathi H, Nelson N, Karnezis AN, Chien J. Int J Mol Sci; 2020 Oct 28; 21(21):. PubMed ID: 33126568 [Abstract] [Full Text] [Related]
20. Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation. Gao G, Wong J, Zhang J, Mao I, Shravah J, Wu Y, Xiao A, Li X, Luo H. J Virol; 2010 Nov 28; 84(21):11056-66. PubMed ID: 20719955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]